Saturday 17 October 2026
Export PDEX’s income statement to Excel — free account
Pro-Dex, Inc.
PDEX Healthcare Medical Instruments & Supplies
Pro-Dex, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $77.5 million, up 16.5% from fiscal 2025. In the quarter to June 2026, revenue grew 16.7%, EPS grew 143.2%, free cash flow fell 79.0% and total debt rose 43.5%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
58.26
1.76
−2.93%
Follow PDEX
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 5 | 7 | 2 | 3 | 6 | 6 | 6 | 6 |
P/E ratio |
4.88 | 17.37 | 13.42 | 11.37 | 19.93 | 12.70 | 10.27 | 29.13 | 15.81 | 13.84 |
Altman Z-Score |
7.91 | 8.69 | 6.42 | 6.36 | 5.73 | 3.66 | 4.44 | 4.65 | 6.63 | 7.38 |
P/S ratio |
1.13 | 1.26 | 2.05 | 2.00 | 3.05 | 1.38 | 1.48 | 1.19 | 2.15 | 2.44 |
Altman Z″-Score (non-manufacturers) |
9.67 | 11.83 | 7.90 | 7.69 | 5.83 | 5.66 | 6.64 | 7.06 | 8.16 | 8.66 |
P/FCF ratio |
9.56 | 12.96 | 28.79 | 15.89 | 0.00 | 0.00 | 15.31 | 12.33 | 0.00 | 28.08 |
Beneish M-Score |
(0.24) | (3.11) | (2.35) | (1.50) | (0.71) | (1.50) | (2.33) | (2.74) | (1.69) | (1.11) |
P/Operating CF |
18.89 | 21.74 | 231.17 | 26.33 | 160.05 | (10.99) | 108.78 | 61.44 | (829.41) | (691.88) |
P/B ratio |
1.81 | 1.64 | 3.28 | 3.66 | 5.78 | 2.28 | 2.16 | 2.08 | 3.92 | 3.97 |
Price to Tangible BV |
1.83 | 1.66 | 3.30 | 3.69 | 5.83 | 2.29 | 2.16 | 2.08 | 3.92 | 4.67 |
EV/Sales |
0.91 | 0.94 | 1.85 | 1.84 | 3.22 | 1.59 | 1.59 | 1.21 | 2.19 | 2.49 |
EV/EBITDA |
5.87 | 5.28 | 9.22 | 8.37 | 23.30 | 11.22 | 11.02 | 7.78 | 12.20 | 13.39 |
EV/Operating CF |
6.18 | 6.79 | 15.09 | 12.94 | (58.98) | (78.68) | 13.37 | 10.43 | (86.55) | 26.62 |
EV/FCF |
7.69 | 9.59 | 25.94 | 14.59 | (11.80) | (26.47) | 16.40 | 12.46 | (49.16) | 28.67 |
Quick Ratio |
3.28 | 4.29 | 3.17 | 2.70 | 2.54 | 1.50 | 1.45 | 1.61 | 1.68 | 2.40 |
Current Ratio |
4.76 | 6.72 | 4.88 | 4.34 | 3.99 | 2.74 | 3.20 | 2.84 | 3.23 | 4.10 |
Net Debt/EBITDA |
(1.43) | (1.86) | (1.01) | (0.74) | 1.24 | 1.46 | 0.73 | 0.08 | 0.17 | 0.27 |
Debt/Assets |
0.37% | 0.03% | 15.42% | 10.55% | 28.61% | 20.88% | 17.20% | 14.36% | 15.11% | 17.80% |
Debt/Equity |
0.00 | 0.00 | 0.23 | 0.17 | 0.57 | 0.40 | 0.28 | 0.24 | 0.25 | 0.28 |
Asset Turnover |
1.60 | 1.24 | 1.20 | 1.23 | 1.06 | 0.94 | 0.91 | 1.03 | 1.17 | 1.14 |
Operating CF/Net income |
0.64 | 1.91 | 0.80 | 0.81 | (0.34) | (0.19) | 0.77 | 2.93 | (0.19) | 0.53 |
Capex/Depreciation |
(0.95) | (0.57) | (3.13) | (0.96) | (11.30) | (2.04) | (1.12) | (0.84) | (1.00) | (0.34) |
Interest Coverage |
228.08 | 341.71 | 22.72 | 29.94 | 12.86 | 11.04 | 10.81 | 12.85 | 12.89 | 16.00 |
| 45.02% | 10.46% | 24.20% | 33.89% | 31.52% | 20.09% | 24.81% | 6.81% | 26.60% | 32.43% | |
| 36.98% | 8.94% | 18.26% | 21.58% | 17.27% | 10.23% | 14.02% | 4.08% | 15.80% | 20.14% | |
ROIC |
19.33% | 15.14% | 27.19% | 33.05% | 10.63% | 9.40% | 9.89% | 14.21% | 17.25% | 15.75% |
Return on Tangible Assets |
46.00% | 10.41% | 21.49% | 30.36% | 21.26% | 14.75% | 21.68% | 6.09% | 20.46% | 26.47% |
Average Days of Receivables |
58.85 | 48.01 | 55.08 | 54.02 | 104.93 | 133.56 | 78.82 | 94.14 | 95.86 | 102.73 |
Research and Development Expense of Revenue |
5.58% | 8.43% | 6.93% | 6.65% | 11.53% | 7.09% | 6.08% | 5.92% | 5.46% | 4.31% |
Selling, General and Administrative Expense of Revenue |
14.19% | 11.77% | 10.70% | 10.81% | 12.27% | 11.88% | 9.08% | 7.78% | 7.79% | 10.31% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
Share Based Compensation of Revenue |
0.01% | 0.86% | 0.14% | 0.82% | 2.37% | 3.03% | 1.66% | 1.12% | 0.83% | 0.89% |
Graham Net Nets |
0.39 | 0.48 | 0.22 | 0.15 | 0.04 | 0.13 | 0.16 | 0.23 | 0.16 | 0.14 |
Graham Number |
9.81 | 5.86 | 9.51 | 13.11 | 13.51 | 14.06 | 19.24 | 11.18 | 26.30 | 37.49 |
Earnings Yield |
20.49% | 5.76% | 7.45% | 8.80% | 5.02% | 7.87% | 9.74% | 3.43% | 6.32% | 7.22% |
Free Cash Flow Yield |
10.46% | 7.71% | 3.47% | 6.29% | (8.95%) | (4.34%) | 6.53% | 8.11% | (2.06%) | 3.56% |
Revenue per Share |
5.43 | 5.22 | 6.48 | 8.91 | 10.02 | 11.56 | 12.91 | 15.39 | 20.25 | 24.04 |
Operating CF per Share |
0.80 | 0.72 | 0.79 | 1.26 | (0.55) | (0.23) | 1.53 | 1.78 | (0.51) | 2.24 |
Capex per Share |
(0.16) | (0.21) | (0.33) | (0.14) | (2.19) | (0.46) | (0.27) | (0.28) | (0.38) | (0.15) |
Free Cash Flow per Share |
0.64 | 0.51 | 0.46 | 1.12 | (2.73) | (0.69) | 1.26 | 1.50 | (0.89) | 2.10 |
Cash per Share |
1.22 | 1.72 | 2.26 | 2.30 | 1.32 | 0.44 | 1.14 | 1.96 | 2.18 | 2.90 |
Shareholders Equity per Share |
3.39 | 4.01 | 4.06 | 4.87 | 5.29 | 6.99 | 8.85 | 8.82 | 11.14 | 14.77 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.39 | 4.01 | 4.06 | 4.87 | 5.29 | 6.99 | 8.85 | 8.82 | 11.14 | 14.77 |
Free Cash Flow |
2.60 | 2.19 | 1.94 | 4.39 | (10.38) | (2.52) | 4.49 | 5.24 | (2.93) | 6.76 |
Working Capital |
9.70 | 13.82 | 16.58 | 17.45 | 18.74 | 19.81 | 21.30 | 23.72 | 32.67 | 40.27 |
Capital Expenditures |
(0.63) | (0.90) | (1.39) | (0.56) | (8.31) | (1.67) | (0.97) | (0.98) | (1.25) | (0.48) |
Net Current Asset Value |
9.64 | 13.59 | 12.33 | 10.61 | 4.78 | 7.51 | 10.75 | 15.00 | 22.74 | 26.37 |
EV/EBIT |
7.30 | 8.78 | 10.04 | 9.06 | 27.08 | 13.01 | 12.68 | 9.05 | 13.62 | 14.84 |
Capex to Sales |
0.03 | 0.04 | 0.05 | 0.02 | 0.22 | 0.04 | 0.02 | 0.02 | 0.02 | 0.01 |
Price to Operating Income |
9.08 | 11.88 | 11.15 | 9.86 | 25.64 | 11.32 | 11.84 | 8.95 | 13.42 | 14.54 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.49 | 0.90 | 0.16 | 0.22 | 0.07 | 0.07 | 0.08 | 0.10 | 0.11 | 0.12 |
Cash ROIC |
13.91% | 8.88% | 6.37% | 14.00% | (28.34%) | (6.75%) | 10.07% | 11.58% | (5.52%) | 9.62% |
Accounts Receivable Turnover |
8.61 | 6.92 | 7.70 | 7.53 | 4.73 | 3.20 | 3.64 | 4.52 | 4.24 | 3.95 |
Accounts Payable Turnover |
14.76 | 12.95 | 11.30 | 10.95 | 11.50 | 9.56 | 11.07 | 11.60 | 10.32 | 11.99 |
Inventory Turnover |
4.58 | 3.88 | 3.27 | 3.00 | 2.93 | 2.74 | 2.31 | 2.50 | 2.51 | 2.44 |
Average Days of Payables |
28.67 | 27.22 | 41.89 | 33.06 | 34.15 | 47.49 | 24.75 | 41.92 | 35.77 | 29.23 |
Days of Inventory on Hand |
76.28 | 110.41 | 130.94 | 138.62 | 125.93 | 160.07 | 177.00 | 141.84 | 172.20 | 147.19 |
Average Receivables |
2.55 | 3.25 | 3.53 | 4.63 | 8.04 | 13.16 | 12.67 | 11.92 | 15.69 | 19.66 |
Average Payables |
1.00 | 1.12 | 1.54 | 1.98 | 2.13 | 3.02 | 3.01 | 3.39 | 4.56 | 4.44 |
Average Inventory |
3.22 | 3.74 | 5.32 | 7.24 | 8.34 | 10.56 | 14.42 | 15.72 | 18.74 | 21.84 |
Average Assets |
13.75 | 18.13 | 22.72 | 28.32 | 35.72 | 44.70 | 50.46 | 52.15 | 56.83 | 67.85 |
Average Common Equity |
11.29 | 15.49 | 17.14 | 18.04 | 19.57 | 22.76 | 28.51 | 31.23 | 33.75 | 42.13 |
Columns are period end dates